LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has initiated an operational, technical, and commercial evaluation to support a potential integration of installment-based healthcare payment capabilities through Cashea, one of Venezuela’s leading buy-now-pay-later financial technology platforms.
The proposed initiative is designed to evaluate ways to reduce upfront financial barriers for patients seeking access to private healthcare services, consultations, diagnostics, wellness programs, and other eligible healthcare offerings through the LataMed AI ecosystem. By addressing affordability challenges, the Company believes it can support greater patient engagement, increased healthcare utilization, stronger platform adoption, and broader access to private healthcare services.
Management believes that improving payment accessibility may strengthen LataMed AI’s position as a technology-enabled healthcare marketplace serving patients, providers, and healthcare partners throughout Latin America. The Company expects that a potential Cashea-related payment integration, if successfully completed, could support its broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a more scalable healthcare marketplace.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem. We believe initiatives such as this have the potential to strengthen patient acquisition, improve engagement, and support long-term platform growth.”
The Company has not entered into a definitive commercial agreement related to this initiative as of the date of this release. Completion of any integration remains subject to further commercial discussions, technical implementation requirements, regulatory review, and customary business conditions. LataMed AI intends to provide additional updates as material developments occur.
The announcement highlights the ongoing challenge of healthcare affordability in emerging markets. By potentially offering installment payments, LataMed AI could lower the upfront cost barrier for patients, enabling them to access private medical care that might otherwise be unaffordable. This move may also drive higher patient volumes and platform usage, benefiting both healthcare providers and the company itself.
For more information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at https://www.sec.gov.
